Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2004-00703-18 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| eprosartan/HCTZ | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Blood pressure reduction |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of responder rates |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Director Solvay | Solvay Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Site 26 | Calgary | Canada | ||||
| Site 27 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Montreal |
| Canada |
| Site 30 | Québec | Canada |
| Site 31 | Thornhill | Canada |
| Site 28 | Vancouver | Canada |
| Site 29 | Winnipeg | Canada |
| Site 39 | Holbæk | Denmark |
| Site 38 | Roskilde | Denmark |
| Site 40 | Viborg | Denmark |
| Site 4 | Anzin | France |
| Site 3 | Blois | France |
| Site 10 | Chemellier | France |
| Site 11 | Cholet | France |
| Site 15 | Cholet | France |
| Site 16 | Cholet | France |
| Site 14 | La Jubaudière | France |
| Site 13 | Le Mesnil-en-Vallée | France |
| Site 7 | Mûrs-Erigné | France |
| Site 12 | Saint Pierre Montlim | France |
| Site 9 | Saumur | France |
| Site 8 | Segré | France |
| Site 6 | Thouars | France |
| Site 2 | Tours | France |
| Site 5 | Vieux-Condé | France |
| Site 20 | Bad Muenster | Germany |
| Site 22 | Flörsheim | Germany |
| Site 19 | Kirweiler | Germany |
| Site 21 | Lambrecht | Germany |
| Site 25 | Lindau | Germany |
| Site 24 | Lutherstadt | Germany |
| Site 18 | Lüneburg | Germany |
| Site 17 | Riesa | Germany |
| Site 23 | Waldbrunn | Germany |
| Site 62 | Bologna | Italy |
| Site 60 | Naples | Italy |
| Site 58 | Padova | Italy |
| Site 59 | Palermo | Italy |
| Site 63 | Pavia | Italy |
| Site 61 | Pisa | Italy |
| Site 64 | Torino | Italy |
| Site 43 | Ålesund | Norway |
| Site 42 | Bergen | Norway |
| Site 44 | Horten | Norway |
| Site 41 | Skedsmokorset | Norway |
| Site 55 | Badajoz | Spain |
| Site 51 | Badalona | Spain |
| Site 56 | Barcelona | Spain |
| Site 57 | Barcelona | Spain |
| Site 54 | Ciudad Real | Spain |
| Site 53 | Granada | Spain |
| Site 52 | Madrid | Spain |
| Site 48 | Ängelholm | Sweden |
| Site 47 | Gothenburg | Sweden |
| Site 46 | Helsingborg | Sweden |
| Site 45 | Kristianstat | Sweden |
| Site 50 | Malmö | Sweden |
| Site 49 | Stockholm | Sweden |
| Site 33 | Aberdeen | United Kingdom |
| Site 36 | Bath | United Kingdom |
| Site 37 | Liverpool | United Kingdom |
| Site 34 | Manchester | United Kingdom |
| Site 32 | Oldham | United Kingdom |
| Site 35 | Rugby | United Kingdom |
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D003924 | Diabetes Mellitus, Type 2 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided